BioHarvest Sciences Inc.
BHST
$6.71
-$0.09-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.47% | 59.14% | -55.70% | 75.89% | -775.13% |
| Total Depreciation and Amortization | 97.52% | 57.87% | 61.75% | 70.81% | 2.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.54% | -86.01% | 370.40% | -2,005.88% | 410.67% |
| Change in Net Operating Assets | 102.22% | -26.76% | -103.25% | 219.44% | -182.12% |
| Cash from Operations | 9.57% | 20.21% | -76.78% | 66.71% | 4.65% |
| Capital Expenditure | -208.11% | -35.05% | -16.36% | -365.40% | 40.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -206.31% | -37.46% | -7.27% | -426.70% | 40.96% |
| Total Debt Issued | -- | -53.32% | -- | -- | -- |
| Total Debt Repaid | -71.32% | -855.56% | -72.63% | -23.96% | -55.42% |
| Issuance of Common Stock | -- | -- | -- | 1,072.46% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,791.38% | -64.99% | -113.86% | -2.97% | -118.80% |
| Foreign Exchange rate Adjustments | -33.33% | -159.72% | -400.00% | 70.00% | 86.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 152.68% | -109.96% | -848.62% | 14.55% | -33.64% |